DOCSLIB.ORG

Current and Past Strategies for Bacterial Culture in Clinical Microbiology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Current and Past Strategies for Bacterial Culture in Clinical Microbiology Current and Past Strategies for Bacterial Culture in Clinical Microbiology Jean-Christophe Lagier, Sophie Edouard, Isabelle Pagnier, Oleg Mediannikov, Michel Drancourt, Didier Raoult Aix Marseille Université, URMITE, UM63, CNRS 7278, IRD 198, INSERM 1095, Marseille, France SUMMARY ..................................................................................................................................................209 INTRODUCTION ............................................................................................................................................209 Downloaded from EARLY STRATEGIES AND GENERAL PRINCIPLES ...........................................................................................................209 Nonselective Culture Media ..............................................................................................................................210 Solid agar and coagulated serum......................................................................................................................210 Enriched media ........................................................................................................................................210 Selective Culture Media ..................................................................................................................................210 Organic and inorganic components and minerals ....................................................................................................210 Antibiotics and antiseptics.............................................................................................................................210 Sample Decontamination ................................................................................................................................210 Temperature and Atmosphere Control ..................................................................................................................210 http://cmr.asm.org/ Temperature...........................................................................................................................................210 Atmospheres ..........................................................................................................................................210 (i) Aerophilic and anaerobic conditions .............................................................................................................210 (ii) Microaerophilic conditions.......................................................................................................................210 Incubation Time ..........................................................................................................................................210 Improving Collection and Transport Time to the Laboratory.............................................................................................211 SPECIFIC STRATEGIES FOR FASTIDIOUS BACTERIA .......................................................................................................211 Mycoplasma ..............................................................................................................................................211 Anaerobes................................................................................................................................................211 Brief history of earlier methods ........................................................................................................................211 (i) Physical reduction of oxygen tension ............................................................................................................211 on January 7, 2015 by GAZI UNIVERSITESI (ii) Chemical reduction by reducing agents.........................................................................................................211 Constituents of anaerobic media ......................................................................................................................212 (i) Major and minor constituents of suitable anaerobic media ......................................................................................212 (ii) Growth factors ...................................................................................................................................212 Anaerobic incubation systems used to increase the ability to cultivate anaerobes....................................................................212 (i) Anaerobic jars ....................................................................................................................................212 (ii) Roll tube method ................................................................................................................................212 (iii) Anaerobic chambers ............................................................................................................................212 Perspectives on anaerobic culture.....................................................................................................................212 Spirochetes...............................................................................................................................................212 Mycobacteria .............................................................................................................................................214 Archaea...................................................................................................................................................215 INTRACELLULAR BACTERIAL CULTURE ....................................................................................................................217 Culture in Embryonated Eggs ............................................................................................................................217 Animal Inoculation .......................................................................................................................................217 Coculture with Amoebae ................................................................................................................................218 History .................................................................................................................................................218 Methods ...............................................................................................................................................218 (i) Coculture with amoebae..........................................................................................................................218 (ii) Isolation of wild amoebae with their symbionts .................................................................................................219 (iii) Protozoa used for ARM culture...................................................................................................................219 (continued) Citation Lagier J-C, Edouard S, Pagnier I, Mediannikov O, Drancourt M, Raoult D. 2015. Current and past strategies for bacterial culture in clinical microbiology. Clin Microbiol Rev 28:208–236. doi:10.1128/CMR.00110-14. Address correspondence to Didier Raoult, [email protected]. Copyright © 2015, American Society for Microbiology. All Rights Reserved. doi:10.1128/CMR.00110-14 208 cmr.asm.org Clinical Microbiology Reviews January 2015 Volume 28 Number 1 Bacterial Culture in Clinical Microbiology Results .................................................................................................................................................219 (i) Alphaproteobacteria ..............................................................................................................................219 (ii) Betaproteobacteria ...............................................................................................................................219 (iii) Gammaproteobacteria...........................................................................................................................219 (iv) Epsilonproteobacteria ............................................................................................................................220 (v) Firmicutes ........................................................................................................................................220 (vi) Bacteroidetes.....................................................................................................................................220 (vii) Actinobacteria...................................................................................................................................220 (viii) Chlamydia ......................................................................................................................................220 (ix) Endomicrobia ....................................................................................................................................220 (x) TM6 phylum .....................................................................................................................................221 Use in clinical microbiology............................................................................................................................221 Perspectives ...........................................................................................................................................221 Downloaded from Cell Culture ...............................................................................................................................................221
Load more

Recommended publications
  • Distribution of Tick-Borne Diseases in China Xian-Bo Wu1, Ren-Hua Na2, Shan-Shan Wei2, Jin-Song Zhu3 and Hong-Juan Peng2*
    Wu et al. Parasites & Vectors 2013, 6:119 http://www.parasitesandvectors.com/content/6/1/119 REVIEW Open Access Distribution of tick-borne diseases in China Xian-Bo Wu1, Ren-Hua Na2, Shan-Shan Wei2, Jin-Song Zhu3 and Hong-Juan Peng2* Abstract As an important contributor to vector-borne diseases in China, in recent years, tick-borne diseases have attracted much attention because of their increasing incidence and consequent significant harm to livestock and human health. The most commonly observed human tick-borne diseases in China include Lyme borreliosis (known as Lyme disease in China), tick-borne encephalitis (known as Forest encephalitis in China), Crimean-Congo hemorrhagic fever (known as Xinjiang hemorrhagic fever in China), Q-fever, tularemia and North-Asia tick-borne spotted fever. In recent years, some emerging tick-borne diseases, such as human monocytic ehrlichiosis, human granulocytic anaplasmosis, and a novel bunyavirus infection, have been reported frequently in China. Other tick-borne diseases that are not as frequently reported in China include Colorado fever, oriental spotted fever and piroplasmosis. Detailed information regarding the history, characteristics, and current epidemic status of these human tick-borne diseases in China will be reviewed in this paper. It is clear that greater efforts in government management and research are required for the prevention, control, diagnosis, and treatment of tick-borne diseases, as well as for the control of ticks, in order to decrease the tick-borne disease burden in China. Keywords: Ticks, Tick-borne diseases, Epidemic, China Review (Table 1) [2,4]. Continuous reports of emerging tick-borne Ticks can carry and transmit viruses, bacteria, rickettsia, disease cases in Shandong, Henan, Hebei, Anhui, and spirochetes, protozoans, Chlamydia, Mycoplasma,Bartonia other provinces demonstrate the rise of these diseases bodies, and nematodes [1,2].
    [Show full text]
  • Inactivation of CRISPR-Cas Systems by Anti-CRISPR Proteins in Diverse Bacterial Species April Pawluk1, Raymond H.J
    LETTERS PUBLISHED: 13 JUNE 2016 | ARTICLE NUMBER: 16085 | DOI: 10.1038/NMICROBIOL.2016.85 Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species April Pawluk1, Raymond H.J. Staals2, Corinda Taylor2, Bridget N.J. Watson2, Senjuti Saha3, Peter C. Fineran2, Karen L. Maxwell4* and Alan R. Davidson1,3* CRISPR-Cas systems provide sequence-specific adaptive immu- MGE-encoded mechanisms that inhibit CRISPR-Cas systems. In nity against foreign nucleic acids1,2. They are present in approxi- support of this hypothesis, phages infecting Pseudomonas aeruginosa mately half of all sequenced prokaryotes3 and are expected to were found to encode diverse families of proteins that inhibit constitute a major barrier to horizontal gene transfer. We pre- the CRISPR-Cas systems of their host through several distinct viously described nine distinct families of proteins encoded in mechanisms4,5,17,18. However, homologues of these anti-CRISPR Pseudomonas phage genomes that inhibit CRISPR-Cas function4,5. proteins were found only within the Pseudomonas genus. Here, We have developed a bioinformatic approach that enabled us to we describe a bioinformatic approach that allowed us to identify discover additional anti-CRISPR proteins encoded in phages five novel families of functional anti-CRISPR proteins encoded in and other mobile genetic elements of diverse bacterial phages and other putative MGEs in species spanning the diversity species. We show that five previously undiscovered families of Proteobacteria. of anti-CRISPRs inhibit the type I-F CRISPR-Cas systems of The nine previously characterized anti-CRISPR protein families both Pseudomonas aeruginosa and Pectobacterium atrosepticum, possess no common sequence motifs, so we used genomic context to and a dual specificity anti-CRISPR inactivates both type I-F search for novel anti-CRISPR genes.
    [Show full text]
  • (Batch Learning Self-Organizing Maps), to the Microbiome Analysis of Ticks
    Title A novel approach, based on BLSOMs (Batch Learning Self-Organizing Maps), to the microbiome analysis of ticks Nakao, Ryo; Abe, Takashi; Nijhof, Ard M; Yamamoto, Seigo; Jongejan, Frans; Ikemura, Toshimichi; Sugimoto, Author(s) Chihiro The ISME Journal, 7(5), 1003-1015 Citation https://doi.org/10.1038/ismej.2012.171 Issue Date 2013-03 Doc URL http://hdl.handle.net/2115/53167 Type article (author version) File Information ISME_Nakao.pdf Instructions for use Hokkaido University Collection of Scholarly and Academic Papers : HUSCAP A novel approach, based on BLSOMs (Batch Learning Self-Organizing Maps), to the microbiome analysis of ticks Ryo Nakao1,a, Takashi Abe2,3,a, Ard M. Nijhof4, Seigo Yamamoto5, Frans Jongejan6,7, Toshimichi Ikemura2, Chihiro Sugimoto1 1Division of Collaboration and Education, Research Center for Zoonosis Control, Hokkaido University, Kita-20, Nishi-10, Kita-ku, Sapporo, Hokkaido 001-0020, Japan 2Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga 526-0829, Japan 3Graduate School of Science & Technology, Niigata University, 8050, Igarashi 2-no-cho, Nishi- ku, Niigata 950-2181, Japan 4Institute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Königsweg 67, 14163 Berlin, Germany 5Miyazaki Prefectural Institute for Public Health and Environment, 2-3-2 Gakuen Kibanadai Nishi, Miyazaki 889-2155, Japan 6Utrecht Centre for Tick-borne Diseases (UCTD), Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584 CL Utrecht, The Netherlands 7Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, 0110 Onderstepoort, South Africa aThese authors contributed equally to this work. Keywords: BLSOMs/emerging diseases/metagenomics/microbiomes/symbionts/ticks Running title: Tick microbiomes revealed by BLSOMs Subject category: Microbe-microbe and microbe-host interactions Abstract Ticks transmit a variety of viral, bacterial and protozoal pathogens, which are often zoonotic.
    [Show full text]
  • Compendium of Measures to Control Chlamydia Psittaci Infection Among
    Compendium of Measures to Control Chlamydia psittaci Infection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017 Author(s): Gary Balsamo, DVM, MPH&TMCo-chair Angela M. Maxted, DVM, MS, PhD, Dipl ACVPM Joanne W. Midla, VMD, MPH, Dipl ACVPM Julia M. Murphy, DVM, MS, Dipl ACVPMCo-chair Ron Wohrle, DVM Thomas M. Edling, DVM, MSpVM, MPH (Pet Industry Joint Advisory Council) Pilar H. Fish, DVM (American Association of Zoo Veterinarians) Keven Flammer, DVM, Dipl ABVP (Avian) (Association of Avian Veterinarians) Denise Hyde, PharmD, RP Preeta K. Kutty, MD, MPH Miwako Kobayashi, MD, MPH Bettina Helm, DVM, MPH Brit Oiulfstad, DVM, MPH (Council of State and Territorial Epidemiologists) Branson W. Ritchie, DVM, MS, PhD, Dipl ABVP, Dipl ECZM (Avian) Mary Grace Stobierski, DVM, MPH, Dipl ACVPM (American Veterinary Medical Association Council on Public Health and Regulatory Veterinary Medicine) Karen Ehnert, and DVM, MPVM, Dipl ACVPM (American Veterinary Medical Association Council on Public Health and Regulatory Veterinary Medicine) Thomas N. Tully JrDVM, MS, Dipl ABVP (Avian), Dipl ECZM (Avian) (Association of Avian Veterinarians) Source: Journal of Avian Medicine and Surgery, 31(3):262-282. Published By: Association of Avian Veterinarians https://doi.org/10.1647/217-265 URL: http://www.bioone.org/doi/full/10.1647/217-265 BioOne (www.bioone.org) is a nonprofit, online aggregation of core research in the biological, ecological, and environmental sciences. BioOne provides a sustainable online platform for over 170 journals and books published by nonprofit societies, associations, museums, institutions, and presses. Your use of this PDF, the BioOne Web site, and all posted and associated content indicates your acceptance of BioOne’s Terms of Use, available at www.bioone.org/page/terms_of_use.
    [Show full text]
  • Borrelia Burgdorferi and Treponema Pallidum: a Comparison of Functional Genomics, Environmental Adaptations, and Pathogenic Mechanisms
    PERSPECTIVE SERIES Bacterial polymorphisms Martin J. Blaser and James M. Musser, Series Editors Borrelia burgdorferi and Treponema pallidum: a comparison of functional genomics, environmental adaptations, and pathogenic mechanisms Stephen F. Porcella and Tom G. Schwan Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, Montana, USA Address correspondence to: Tom G. Schwan, Rocky Mountain Laboratories, 903 South 4th Street, Hamilton, Montana 59840, USA. Phone: (406) 363-9250; Fax: (406) 363-9445; E-mail: [email protected]. Spirochetes are a diverse group of bacteria found in (6–8). Here, we compare the biology and genomes of soil, deep in marine sediments, commensal in the gut these two spirochetal pathogens with reference to their of termites and other arthropods, or obligate parasites different host associations and modes of transmission. of vertebrates. Two pathogenic spirochetes that are the focus of this perspective are Borrelia burgdorferi sensu Genomic structure lato, a causative agent of Lyme disease, and Treponema A striking difference between B. burgdorferi and T. pal- pallidum subspecies pallidum, the agent of venereal lidum is their total genomic structure. Although both syphilis. Although these organisms are bound togeth- pathogens have small genomes, compared with many er by ancient ancestry and similar morphology (Figure well known bacteria such as Escherichia coli and Mycobac- 1), as well as by the protean nature of the infections terium tuberculosis, the genomic structure of B. burgdorferi they cause, many differences exist in their life cycles, environmental adaptations, and impact on human health and behavior. The specific mechanisms con- tributing to multisystem disease and persistent, long- term infections caused by both organisms in spite of significant immune responses are not yet understood.
    [Show full text]
  • Coxiella Burnetii
    SENTINEL LEVEL CLINICAL LABORATORY GUIDELINES FOR SUSPECTED AGENTS OF BIOTERRORISM AND EMERGING INFECTIOUS DISEASES Coxiella burnetii American Society for Microbiology (ASM) Revised March 2016 For latest revision, see web site below: https://www.asm.org/Articles/Policy/Laboratory-Response-Network-LRN-Sentinel-Level-C ASM Subject Matter Expert: David Welch, Ph.D. Medical Microbiology Consulting Dallas, TX [email protected] ASM Sentinel Laboratory Protocol Working Group APHL Advisory Committee Vickie Baselski, Ph.D. Barbara Robinson-Dunn, Ph.D. Patricia Blevins, MPH University of Tennessee at Department of Clinical San Antonio Metro Health Memphis Pathology District Laboratory Memphis, TN Beaumont Health System [email protected] [email protected] Royal Oak, MI BRobinson- Erin Bowles David Craft, Ph.D. [email protected] Wisconsin State Laboratory of Penn State Milton S. Hershey Hygiene Medical Center Michael A. Saubolle, Ph.D. [email protected] Hershey, PA Banner Health System [email protected] Phoenix, AZ Christopher Chadwick, MS [email protected] Association of Public Health Peter H. Gilligan, Ph.D. m Laboratories University of North Carolina [email protected] Hospitals/ Susan L. Shiflett Clinical Microbiology and Michigan Department of Mary DeMartino, BS, Immunology Labs Community Health MT(ASCP)SM Chapel Hill, NC Lansing, MI State Hygienic Laboratory at the [email protected] [email protected] University of Iowa [email protected] Larry Gray, Ph.D. Alice Weissfeld, Ph.D. TriHealth Laboratories and Microbiology Specialists Inc. Harvey Holmes, PhD University of Cincinnati College Houston, TX Centers for Disease Control and of Medicine [email protected] Prevention Cincinnati, OH om [email protected] [email protected] David Welch, Ph.D.
    [Show full text]
  • Novel Small Rnas Expressed by Bartonella Bacilliformis Under Multiple Conditions 2 Reveal Potential Mechanisms for Persistence in the Sand Fly Vector and Human 3 Host
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235903; this version posted August 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Novel small RNAs expressed by Bartonella bacilliformis under multiple conditions 2 reveal potential mechanisms for persistence in the sand fly vector and human 3 host 4 5 6 Shaun Wachter1, Linda D. Hicks1, Rahul Raghavan2 and Michael F. Minnick1* 7 8 9 10 1 Program in Cellular, Molecular & Microbial Biology, Division of Biological Sciences, 11 University of Montana, Missoula, Montana, United States of America 12 2 Department of Biology and Center for Life in Extreme Environments, Portland State 13 University, Portland, Oregon, United States of America 14 15 16 17 * Corresponding author 18 E-mail: [email protected] (MFM) 19 20 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.04.235903; this version posted August 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 21 Abstract 22 Bartonella bacilliformis, the etiological agent of Carrión’s disease, is a Gram-negative, 23 facultative intracellular alphaproteobacterium. Carrión’s disease is an emerging but neglected 24 tropical illness endemic to Peru, Colombia, and Ecuador. B. bacilliformis is spread between 25 humans through the bite of female phlebotomine sand flies.
    [Show full text]
  • 09 Piqueras.Qxp
    PERSPECTIVES INTERNATIONAL MICROBIOLOGY (2007) 10:217-226 DOI: 10.2436/20.1501.01.30 ISSN: 1139-6709 www.im.microbios.org Microbiology: a dangerous profession? Mercè Piqueras President, Catalan Association for Science Communication (ACCC), Barcelona, Spain The history of science contains many cases of researchers eases in Minorca from the year 1744 to 1749 to which is pre- who have died because of their professional activity. In the fixed, a short account of the climate, productions, inhabi- field of microbiology, some have died or have come close to tants, and endemical distempers of that island (T. Cadell, D. death from infection by agents that were the subject of their Wilson and G. Nicol, London, 1751), which he dedicated to research (Table 1). Infections that had a lethal outcome were the Society of Surgeons of His Majesty’s Royal Navy. usually accidental. Sometimes, however, researchers inocu- Minorcan historian of science Josep M. Vidal Hernández has lated themselves with the pathogen or did not take preventive described and carefully analyzed Cleghorn’s work in measures against the potential pathogen because they wanted Minorca and his report [43]. According to Vidal, what to prove their hypotheses—or disprove someone else’s— Cleghorn describes is “tertian” fever, which was the name regarding the origin of the infection. Here is an overview of given at the time to fever caused by malaria parasites with a several episodes in the history of microbiology since the mid periodicity of 48 hours. In fact, Cleghorn used quinine to nineteenth century involving researchers or workers in fields treat tertian fever (i.e, malaria), which was not eradicated related to microbiology who have become infected.
    [Show full text]
  • Downloaded 13 April 2017); Using Diamond
    bioRxiv preprint doi: https://doi.org/10.1101/347021; this version posted June 14, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 2 3 4 5 Re-evaluating the salty divide: phylogenetic specificity of 6 transitions between marine and freshwater systems 7 8 9 10 Sara F. Pavera, Daniel J. Muratorea, Ryan J. Newtonb, Maureen L. Colemana# 11 a 12 Department of the Geophysical Sciences, University of Chicago, Chicago, Illinois, USA 13 b School of Freshwater Sciences, University of Wisconsin Milwaukee, Milwaukee, Wisconsin, USA 14 15 Running title: Marine-freshwater phylogenetic specificity 16 17 #Address correspondence to Maureen Coleman, [email protected] 18 bioRxiv preprint doi: https://doi.org/10.1101/347021; this version posted June 14, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 19 Abstract 20 Marine and freshwater microbial communities are phylogenetically distinct and transitions 21 between habitat types are thought to be infrequent. We compared the phylogenetic diversity of 22 marine and freshwater microorganisms and identified specific lineages exhibiting notably high or 23 low similarity between marine and freshwater ecosystems using a meta-analysis of 16S rRNA 24 gene tag-sequencing datasets. As expected, marine and freshwater microbial communities 25 differed in the relative abundance of major phyla and contained habitat-specific lineages; at the 26 same time, however, many shared taxa were observed in both environments. 27 Betaproteobacteria and Alphaproteobacteria sequences had the highest similarity between 28 marine and freshwater sample pairs.
    [Show full text]
  • Chlamydophila Felis Prevalence Chlamydophila Felis Prevalence
    ORIGINAL SCIENTIFIC ARTICLE / IZVORNI ZNANSTVENI ČLANAK A preliminary study of Chlamydophila felis prevalence among domestic cats in the City of Zagreb and Zagreb County in Croatia Gordana Gregurić Gračner*, Ksenija Vlahović, Alenka Dovč, Brigita Slavec, Ljiljana Bedrica, S. Žužul and D. Gračner Introduction Feline chlamydiosis is a disease in do- Rampazzo et al. (2003) investigated mestic cats caused by Chlamydophila felis the prevalence of Cp. felis and feline (Cp. felis), which is primarily a pathogen herpesvirus in cats with conjunctivitis by of the conjunctiva and nasal mucosa using a conventional polymerase chain rather than a pulmonary pathogen. It is reaction (PCR), and discovered that 14 capable of causing acute to chronic con- out of 70 (20%) cats with conjunctivitis junctivitis, with blepharospasm, chem- were positive only on Cp. felis and mixed osis and congestion, a serous to mucop- infections with herpesvirus were present urulent ocular discharge, and rhinitis in 5 of 70 (7%) cats. (Hoover et al., 1978; Sykes, 2005). C. Helps et al. (2005) took oropharyngeal 1 psittaci infection in kittens produces fe- and conjunctival swabs from 1101 cats ver, lethargy, lameness, and reduction and by using a PCR determined Cp. felis in weight gain (Terwee at al., 1998). Ac- in 10% of the 558 swab samples of cats cording to the literature, chlamydiosis with URDT and in 3% of the 558 swab in cats can be treated successfully by samples of cats without URDT. administering potentiated amoxicillin Low et al. (2007) investigated 55 cats for 30 days, which can result in a com- with conjunctivitis, 39 healthy cats and plete clinical recovery with no evidence 32 cats with a history of conjunctivitis of a recurrence for six months (Sturgess that been resolved for at least 3 months.
    [Show full text]
  • The Relapsing Fever Agent Borrelia Hermsii Has Multiple
    Copyright Q 1992 by the Genetics Societyof America The Relapsing Fever AgentBorrelia hermsii Has Multiple Copiesof Its Chromosome and Linear Plasmids Todd Kitten and Alan G. Barbour Departments of Microbiology and Medicine, The Universityof Texas Health Science Center, Sun Antonio, Texas 78284 Manuscript received March 17, 1992 Accepted for publicationJune 25, 1992 ABSTRACT Borrelia hermsii, a spirochete which causes relapsing fever in humans and other mammals, eludes the immune responseby antigenic variationof the “Vmp” proteins.This occurs by replacement of an expressed vrnp gene with a copy of a silent vrnp gene. Silent and expressedvrnp genes are located on separate linearplasmids. To further characterize vrnp recombination, copy numbers were determined for two linear plasmids and for the l-megabase chromosome by comparing hybridization of probes to native DNA with hybridization to recombinant plasmids containing borrelial DNA. Plasmid copy numbers were also estimated by ethidium bromide fluorescence. Total cellular DNA content was determined by spectrophotometry. For borreliasgrown in mice, copy numbers and 95% confidence intervals were 14 (12-17)for an expression plasmid,8 (7-9) for a silent plasmid, and 16 (13-18) for the chromosome. Borrelias grown in broth mediumhad one-fourth to one-half this number of plasmids and chromosomes. Staining of cells with4’,6-diamidino-2-phenylindole revealed DNA to be distributed throughout most of the spirochete’s length. These findings indicate that borrelias organize their total cellular DNA into several complete genomes and thatcells undergoing serotype switches do one or more of the following: (1) coexpress Vmps from switched and unswitched expression plasmids for at least three to five generations, (2)suppress transcription from some expressionplasmid copies, or (3) partition expression plasmids nonrandomly.The lower copy number ofthe silentplasmid indicates that nonreciprocal Vmp gene recombination may result from loss of recombinant silent ” plasmids by segregation.
    [Show full text]
  • What Is Lyme Disease?
    The threat of Lyme disease Dr Roger Evans Consultant Clinical Scientist National Lyme Borreliosis Testing Laboratory What is Lyme disease? • Also known as Lyme borreliosis • An infection caused by Borrelia burgdorferi sensu lato, a gram negative spirochaete bacterium • Transmitted through the bite of an infected tick (Ixodes ricinus in the UK) – a tick needs to be attached to the skin for around 24 hours to transmit Borrelia sp. to a person. • Recognised clinical presentations: early localized, early disseminated and late Lyme disease • There are large gaps in our clinical understanding of Lyme disease, particularly for ‘Post Treatment Lyme Disease Syndrome ‘ Picture credit: James Gathany Ixodes ricinus (tick) ecology/ life cycle Adapted from Manelli et al. 2011 Laboratory samples and cases of LB in Scotland 1996 to 2016 500 7000 450 6000 400 350 5000 300 4000 250 3000 200 Number of cases Number of samples 150 2000 100 1000 50 0 0 Cases Seroneg EM Year Samples GP study (2010-2012) • Three GP practices in NHS Highland region: Nairn, Culloden, Fort William • Number of laboratory cases compared to number of cases treated for Lyme disease without testing • About 2 x number of cases diagnosed by GP without lab testing compared to those that were tested • 2010-2011 • 1440 blood donors • Screened by EIA • EIA positive or equivocal samples confirmed by immunoblot (IB) • 60/1440 (4.2%) IB positive Munro et al (2015) Transfusion Medicine. Letter to the Editor doi: 10.1111/tme.12197 What does it cost? • Netherlands study (2010) – 5 health outcomes:
    [Show full text]